CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $4.63 billion. The enterprise value is $2.75 billion.
| Market Cap | 4.63B |
| Enterprise Value | 2.75B |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, after market close.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 84.92 million shares outstanding. The number of shares has increased by 3.96% in one year.
| Shares Outstanding | 84.92M |
| Shares Change (YoY) | +3.96% |
| Shares Change (QoQ) | +2.64% |
| Owned by Insiders (%) | 1.86% |
| Owned by Institutions (%) | 70.97% |
| Float | 83.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 23.36 |
| PS Ratio | 17.05 |
| Forward PS | 44.30 |
| PB Ratio | 2.22 |
| P/FCF Ratio | n/a |
| PEG Ratio | -0.21 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.81, with a Debt / Equity ratio of 0.11.
| Current Ratio | 17.81 |
| Quick Ratio | n/a |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -11.60% and return on invested capital (ROIC) is -12.88%.
| Return on Equity (ROE) | -11.60% |
| Return on Assets (ROA) | -9.70% |
| Return on Capital (ROIC) | -12.88% |
| Revenue Per Employee | $667,592 |
| Profits Per Employee | -$533,504 |
| Employee Count | 407 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $2.29 million in taxes.
| Income Tax | 2.29M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.13% in the last 52 weeks. The beta is 1.70, so CRSP's price volatility has been higher than the market average.
| Beta (5Y) | 1.70 |
| 52-Week Price Change | -6.13% |
| 50-Day Moving Average | 56.88 |
| 200-Day Moving Average | 61.10 |
| Relative Strength Index (RSI) | 44.32 |
| Average Volume (20 Days) | 1,448,248 |
Short Selling Information
The latest short interest is 15.65 million, so 18.43% of the outstanding shares have been sold short.
| Short Interest | 15.65M |
| Short Previous Month | 14.87M |
| Short % of Shares Out | 18.43% |
| Short % of Float | 18.77% |
| Short Ratio (days to cover) | 11.45 |
Income Statement
In the last 12 months, CRSP had revenue of $271.71 million and -$217.14 million in losses. Loss per share was -$2.69.
| Revenue | 271.71M |
| Gross Profit | 271.71M |
| Operating Income | -298.64M |
| Pretax Income | -214.84M |
| Net Income | -217.14M |
| EBITDA | -195.23M |
| EBIT | -214.84M |
| Loss Per Share | -$2.69 |
Balance Sheet
The company has $2.12 billion in cash and $234.93 million in debt, giving a net cash position of $1.88 billion or $22.19 per share.
| Cash & Cash Equivalents | 2.12B |
| Total Debt | 234.93M |
| Net Cash | 1.88B |
| Net Cash Per Share | $22.19 |
| Equity (Book Value) | 2.08B |
| Book Value Per Share | 24.54 |
| Working Capital | 2.00B |
Cash Flow
In the last 12 months, operating cash flow was -$159.42 million and capital expenditures -$7.13 million, giving a free cash flow of -$166.55 million.
| Operating Cash Flow | -159.42M |
| Capital Expenditures | -7.13M |
| Free Cash Flow | -166.55M |
| FCF Per Share | -$2.04 |
Margins
Gross margin is 100.00%, with operating and profit margins of -109.91% and -79.91%.
| Gross Margin | 100.00% |
| Operating Margin | -109.91% |
| Pretax Margin | -79.07% |
| Profit Margin | -79.91% |
| EBITDA Margin | -71.85% |
| EBIT Margin | -79.07% |
| FCF Margin | -61.30% |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.96% |
| Shareholder Yield | -3.96% |
| Earnings Yield | -4.69% |
| FCF Yield | -3.59% |
Analyst Forecast
The average price target for CRSP is $80.29, which is 47.16% higher than the current price. The consensus rating is "Buy".
| Price Target | $80.29 |
| Price Target Difference | 47.16% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 42.09% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 7.99 and a Piotroski F-Score of 4.
| Altman Z-Score | 7.99 |
| Piotroski F-Score | 4 |